- Home
- GF vs NVCT Comparison
GF vs NVCT Comparison
Compare GF & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GF | NVCT |
|---|---|---|
| Founded | 1990 | 2020 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.9M | 220.0M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | GF | NVCT |
|---|---|---|
| Price | $11.89 | $8.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.33 |
| AVG Volume (30 Days) | 28.1K | ★ 67.0K |
| Earning Date | 01-01-0001 | 02-24-2026 |
| Dividend Yield | ★ 0.82% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.38 | $5.55 |
| 52 Week High | $9.41 | $11.52 |
Technical Indicators
Market Signals| Indicator | GF | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 51.86 | 53.54 |
| Support Level | $11.85 | $7.94 |
| Resistance Level | $12.34 | $8.74 |
| Average True Range (ATR) | 0.19 | 0.43 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 35.13 | 49.49 |
Price Performance
Historical ComparisonAbout GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.